889 related articles for article (PubMed ID: 28818091)
1. Non-canonical soluble amyloid-beta aggregates and plaque buffering: controversies and future directions for target discovery in Alzheimer's disease.
Brody DL; Jiang H; Wildburger N; Esparza TJ
Alzheimers Res Ther; 2017 Aug; 9(1):62. PubMed ID: 28818091
[TBL] [Abstract][Full Text] [Related]
2. Brain amyloid-β oligomers in ageing and Alzheimer's disease.
Lesné SE; Sherman MA; Grant M; Kuskowski M; Schneider JA; Bennett DA; Ashe KH
Brain; 2013 May; 136(Pt 5):1383-98. PubMed ID: 23576130
[TBL] [Abstract][Full Text] [Related]
3. Soluble amyloid-beta buffering by plaques in Alzheimer disease dementia versus high-pathology controls.
Esparza TJ; Gangolli M; Cairns NJ; Brody DL
PLoS One; 2018; 13(7):e0200251. PubMed ID: 29979775
[TBL] [Abstract][Full Text] [Related]
4. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology.
Perez-Nievas BG; Stein TD; Tai HC; Dols-Icardo O; Scotton TC; Barroeta-Espar I; Fernandez-Carballo L; de Munain EL; Perez J; Marquie M; Serrano-Pozo A; Frosch MP; Lowe V; Parisi JE; Petersen RC; Ikonomovic MD; López OL; Klunk W; Hyman BT; Gómez-Isla T
Brain; 2013 Aug; 136(Pt 8):2510-26. PubMed ID: 23824488
[TBL] [Abstract][Full Text] [Related]
5. Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice.
Rijal Upadhaya A; Capetillo-Zarate E; Kosterin I; Abramowski D; Kumar S; Yamaguchi H; Walter J; Fändrich M; Staufenbiel M; Thal DR
Neurobiol Aging; 2012 Nov; 33(11):2641-60. PubMed ID: 22305478
[TBL] [Abstract][Full Text] [Related]
6. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.
Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B
Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234
[TBL] [Abstract][Full Text] [Related]
7. Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer's Disease.
Behl T; Kaur I; Fratila O; Brata R; Bungau S
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050199
[TBL] [Abstract][Full Text] [Related]
8. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease.
Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR
Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982
[TBL] [Abstract][Full Text] [Related]
9. (Bio)chemical Strategies To Modulate Amyloid-β Self-Assembly.
Ayala S; Genevaux P; Hureau C; Faller P
ACS Chem Neurosci; 2019 Aug; 10(8):3366-3374. PubMed ID: 31265239
[TBL] [Abstract][Full Text] [Related]
10. Soluble Amyloid-beta Aggregates from Human Alzheimer's Disease Brains.
Esparza TJ; Wildburger NC; Jiang H; Gangolli M; Cairns NJ; Bateman RJ; Brody DL
Sci Rep; 2016 Dec; 6():38187. PubMed ID: 27917876
[TBL] [Abstract][Full Text] [Related]
11. Application of optogenetic Amyloid-β distinguishes between metabolic and physical damages in neurodegeneration.
Lim CH; Kaur P; Teo E; Lam VYM; Zhu F; Kibat C; Gruber J; Mathuru AS; Tolwinski NS
Elife; 2020 Mar; 9():. PubMed ID: 32228858
[TBL] [Abstract][Full Text] [Related]
12. The antibody aducanumab reduces Aβ plaques in Alzheimer's disease.
Sevigny J; Chiao P; Bussière T; Weinreb PH; Williams L; Maier M; Dunstan R; Salloway S; Chen T; Ling Y; O'Gorman J; Qian F; Arastu M; Li M; Chollate S; Brennan MS; Quintero-Monzon O; Scannevin RH; Arnold HM; Engber T; Rhodes K; Ferrero J; Hang Y; Mikulskis A; Grimm J; Hock C; Nitsch RM; Sandrock A
Nature; 2016 Sep; 537(7618):50-6. PubMed ID: 27582220
[TBL] [Abstract][Full Text] [Related]
13. Diversity of Amyloid-beta Proteoforms in the Alzheimer's Disease Brain.
Wildburger NC; Esparza TJ; LeDuc RD; Fellers RT; Thomas PM; Cairns NJ; Kelleher NL; Bateman RJ; Brody DL
Sci Rep; 2017 Aug; 7(1):9520. PubMed ID: 28842697
[TBL] [Abstract][Full Text] [Related]
14. Amyloid-β dimers in the absence of plaque pathology impair learning and synaptic plasticity.
Müller-Schiffmann A; Herring A; Abdel-Hafiz L; Chepkova AN; Schäble S; Wedel D; Horn AH; Sticht H; de Souza Silva MA; Gottmann K; Sergeeva OA; Huston JP; Keyvani K; Korth C
Brain; 2016 Feb; 139(Pt 2):509-25. PubMed ID: 26657517
[TBL] [Abstract][Full Text] [Related]
15. The interaction of insoluble Amyloid-β with soluble Amyloid-β dimers decreases Amyloid-β plaque numbers.
van Gerresheim EF; Herring A; Gremer L; Müller-Schiffmann A; Keyvani K; Korth C
Neuropathol Appl Neurobiol; 2021 Aug; 47(5):603-610. PubMed ID: 33338256
[TBL] [Abstract][Full Text] [Related]
16. Probing amyloid-β pathology in transgenic Alzheimer's disease (tgArcSwe) mice using MALDI imaging mass spectrometry.
Carlred L; Michno W; Kaya I; Sjövall P; Syvänen S; Hanrieder J
J Neurochem; 2016 Aug; 138(3):469-78. PubMed ID: 27115712
[TBL] [Abstract][Full Text] [Related]
17. Nascent Aβ42 Fibrillization in Synaptic Endosomes Precedes Plaque Formation in a Mouse Model of Alzheimer's-like β-Amyloidosis.
Eckman EA; Clausen DM; Solé-Domėnech S; Lee CW; Sinobas-Pereira C; Domalewski RJ; Nichols MR; Pacheco-Quinto J
J Neurosci; 2023 Dec; 43(50):8812-8824. PubMed ID: 37884349
[TBL] [Abstract][Full Text] [Related]
18. Soluble amyloid beta levels are elevated in the white matter of Alzheimer's patients, independent of cortical plaque severity.
Collins-Praino LE; Francis YI; Griffith EY; Wiegman AF; Urbach J; Lawton A; Honig LS; Cortes E; Vonsattel JP; Canoll PD; Goldman JE; Brickman AM
Acta Neuropathol Commun; 2014 Aug; 2():83. PubMed ID: 25129614
[TBL] [Abstract][Full Text] [Related]
19. BIIB042, a novel γ-secretase modulator, reduces amyloidogenic Aβ isoforms in primates and rodents and plaque pathology in a mouse model of Alzheimer's disease.
Scannevin RH; Chollate S; Brennan MS; Snodgrass-Belt PA; Peng H; Xu L; Jung MY; Bussiere T; Arastu MF; Talreja T; Xin Z; Dunstan RW; Fahrer D; Rohde E; Dunah AW; Wang J; Kumaravel G; Taveras AG; Moore Arnold H; Rhodes KJ
Neuropharmacology; 2016 Apr; 103():57-68. PubMed ID: 26690893
[TBL] [Abstract][Full Text] [Related]
20. New Insights into the Spontaneous Human Alzheimer's Disease-Like Model Octodon degus: Unraveling Amyloid-β Peptide Aggregation and Age-Related Amyloid Pathology.
Cisternas P; Zolezzi JM; Lindsay C; Rivera DS; Martinez A; Bozinovic F; Inestrosa NC
J Alzheimers Dis; 2018; 66(3):1145-1163. PubMed ID: 30412496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
